WELLINGTON MANAGEMENT CO LLP 13D/13G Filings for

WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-03
1:13 pm
Sale		 2020-12-31 13G Teva Pharmaceutical Industries Limited
TEVA		 WELLINGTON MANAGEMENT CO LLP 310,793
0.030%		 -80,813,203decrease
(-99.62%)		 Filing